Tivic Health Systems, Inc.

TIVC

$0.26

-10.46%

N/A-$0.03

Healthcare

Medical - Specialties

NASDAQ

Inactive

Tivic Health Systems, Inc. operates as a late-stage immunotherapeutics company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in ...

Historical Employee Count of TIVC

Current

Change

+642.86%

Minimum

Maximum

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 31, 2025	52	10-K	Mar 30, 2026	View
Dec 31, 2024	7	10-K	Mar 21, 2025	View
Dec 31, 2023	9	10-K	Mar 25, 2024	View
Dec 31, 2022	16	10-K	Mar 31, 2023	View
Dec 31, 2021	7	10-K	Mar 31, 2022	View

Supply Chain of TIVC

Upstream / Downstream / Proxies

Upstream

ALOM Technologies CorporationScorpius Holdings, Inc. (d/b/a Scorpius BioManufacturing)OTCPK:SCPXLarmorBio, Inc.Unnamed Electronic Component Suppliers (China-based)Statera Biopharma, Inc.OTCPK:STABMaxim Group LLCVarious Global Electronic Component Distributors (e.g., DigiKey, Mouser - inferred)

Downstream

Amazon.com, Inc.NASDAQ:AMZN Walmart Inc.NYSE:WMT Best Buy Co., Inc.NYSE:BBY Walgreens Boots Alliance, Inc.NASDAQ:WBAUndisclosed Top 10 Medical Product DistributorBiomedical Advanced Research and Development Authority (BARDA)U.S. Department of Defense / Defense Threat Reduction Agency (DTRA)National Institute of Allergy and Infectious Diseases (NIAID)Third-Party Biotech Clients (Velocity Bioworks CDMO)

Proxies

Valion Bio, Inc.NASDAQ:VBIOScorpius Holdings, Inc.OTCPK:SCPXStatera Biopharma, Inc.OTCPK:STAB

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer